Risk Mitigation Measures: An Important Aspect of the Environmental Risk Assessment of Pharmaceuticals

Risk Mitigation Measures: An Important Aspect of the Environmental Risk Assessment of Pharmaceuticals

Within EU marketing authorization procedures of human and veterinary medicinal products (HMP and VMP), an environmental risk assessment (ERA) has to be performed. In the event that an unacceptable environmental risk is identified, risk mitigation measures (RMM) shall be applied in order to reduce en...

Full description

Bibliographic Details
Main Authors: Markus Liebig, Carolin Floeter, Thorsten Hahn, Wolfgang Koch, Andrea Wenzel, Jörg Römbke
Format: Article
Language:English
Published: MDPI AG 2014-01-01
Series:Toxics
Subjects:
authorization
environmental risk assessment
medicinal products
risk mitigation
Online Access:http://www.mdpi.com/2305-6304/2/1/35

Internet

http://www.mdpi.com/2305-6304/2/1/35

Similar Items